Showing results (151-160 of 251) with videos related to

Sort By:
Pageof 26
AIDS (London, England)|August 13, 2002
Minimal variation in T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patientsLi Xu, Stéphane Hué, Stephen Taylor, et al.
Molecular Cancer Therapeutics|May 6, 2010
Preclinical evaluation of nilotinib efficacy in an imatinib-resistant KIT-driven tumor modelCarleen Cullinane, Anthony Natoli, Yorlon Hui, et al.
Science Translational Medicine|June 24, 2011
Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infantsMartin O C Ota, Aderonke A Odutola, Patrick K Owiafe, et al.
Plos One|September 15, 2015
Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis VaccinesSteven G Smith, Kaatje Smits, Simone A Joosten, et al.
Nature Communications|November 4, 2022
Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infantsIman Satti, Rachel E Wittenberg, Shuailin Li, et al.
Lancet (London, England)|February 9, 2013
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trialMichele D Tameris, Mark Hatherill, Bernard S Landry, et al.
Vaccine|November 10, 2024
Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal routeMarco Polo Peralta Alvarez, Keya Downward, Andrew White, et al.
Blood|July 18, 2014
Human CD68 promoter GFP transgenic mice allow analysis of monocyte to macrophage differentiation in vivoAsif J Iqbal, Eileen McNeill, Theodore S Kapellos, et al.
BMC Infectious Diseases|December 4, 2014
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85ARachel Tanner, Kristina Kakalacheva, Ellen Miller, et al.
Scientific Reports|September 29, 2018
Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infectionMatthew K O'Shea, Rachel Tanner, Julius Müller, et al.
Pageof 26